The International Conference on Pharmaceutical Innovation and Development 2023 Kicked off in Yantai

Yantai Administration for Market Regulation

PR100236

 

YANTAI, China, July 19, 2023 /Xinhua=KYODO JBN/--

 

On the morning of July 13, the International Conference on Pharmaceutical

Innovation and Development 2023 kicked off in Yantai. The conference was hosted

by the People's Government of Shandong Province, co-sponsored by the Chinese

Pharmaceutical Association, the China Pharmaceutical Innovation and Research

Development Association (PhIRDA), the China Society for Drug Regulation and the

Shandong Administration for Market Regulation and co-organized by the People's

Government of Yantai and the Shandong Administration for Market Regulation,

with the theme of "Innovation Leading the High-quality Development", with an

aim to build a platform for cooperation and exchange and invite all circles to

join the Yantai "industrial chain partnership" of biomedicine.

 

At the opening ceremony, the government of Yantai issued the award certificates

to the innovative medical products manufacturers that met the industrial

support policy in 2022, with a total bonus of 136 million Chinese yuan. Five

innovative institutions and the first batch of health and medicine development

sub-funds of Yantai were established, including the Institute of Life Science

and Medical Health, the Yantai Innovation Institute of Stem Cells and

Regenerative Medicine, the National Key Laboratory of Luye Pharma Advanced Drug

Delivery System, the Dongcheng Pharmaceutical National Enterprise Technology

Center and Yantai Biomedicine Industry and Education Integration Community. A

signing ceremony was held for 35 key projects with a total investment of 17.2

billion Chinese yuan.

 

In recent years, Yantai has taken different moves around the aim to build a

demonstrative city for international life science innovation and accelerate its

pace to create new fertile soil for the growth of biomedicine industry, a new

highland for innovation and creativity and a new blue ocean for capital

pooling. Yantai will also include the biomedicine industry into its "9+N"

manufacture clustering and cultivation project and concentrate on setting up

examples to achieve a new leap in its industrial ecology, take new steps

towards industrial park construction, achieve a new speed in pharmaceutical

development and new improvements in the guarantee of elements.

 

Source: Yantai Administration for Market Regulation

 

Image Attachments Links:

 

   Link: https://iop.asianetnews.net/view-attachment?attach-id=441604

 

   Caption: The International Conference on Pharmaceutical Innovation and Development 2023

kicked off in Yantai.

 

   Link: https://iop.asianetnews.net/view-attachment?attach-id=441609

 

   Caption: The International Conference on Pharmaceutical Innovation and Development 2023

kicked off in Yantai.

 

   Link: https://iop.asianetnews.net/view-attachment?attach-id=441610

 

   Caption: The International Conference on Pharmaceutical Innovation and Development 2023

kicked off in Yantai.

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中